Anteris Technologies Global Corp.
$8.98
The Read: 2% on strong Q1 2026 clinical progress and board changes, despite a subsequent 25% drop due to unmet interim data expectations and cash burn concerns.
AVR
Hover to view data
No Data
By creating an account you agree to our Terms of Service and Privacy Policy.
$8.98
The Read: 2% on strong Q1 2026 clinical progress and board changes, despite a subsequent 25% drop due to unmet interim data expectations and cash burn concerns.
No Data